非小细胞肺癌放化疗后局部复发再程放疗的研究进展

doi:10.11904/j.issn.1002-3070.2015.03.015

Abstract

Abstract:

The recurrence rate of non-small cell lung cancer(NSCLC)patients after radiotherapy and chemotherapy have been increasing.The therapy scheme consists of reirradiation、chemotherapy、and chemoradiotherapy,with the purpose of improving the local control and prolonging the survival time.Reirradiation is feasible for locally recurrence of non-small-cell lung cancer patients,treatment is security and could better improve quality of life in patients.The majority of patients are tolerable and have better short-term efficacy,No severe short term radiation induced injury is observed.But the long term radiation induced injury and long term efficacy need further investigation.In the present paper,we review the roles of reirradiation for locally recurrence of non-small-cell lung cancer patients after radiotherapy and chemotherapy and the progress in clinical research.

Key words: Carcinoma, Non-small cell lung, Recurrent, Reirradiation

CLC Number:

R734.2

LV Yan,LI Wenxin,LI Jian,XU Xiangying. Progresses on reirradiation for locally recurrence of non-small-cell lung cancer patients after radiotherapy and chemotherapy[J]. PRACTICAL ONCOLOGY JOURNAL, 2015, 29(3): 259-262.

References

1 陈万青,郑荣寿,张思维,等.2003-2007年中国肺癌发病与死亡分析[J].实用肿瘤学杂志,2012,26(1):6-10.
2 Ohguri T,Imada H,Yahara K,et al.Re-irradiation plus regional hyperthermia for recurrent non-small cell lung cancer:A potential modality for inducing long-term survival in selected patients[J].Lung Cancer,2012,77(1):140-145.
3 Aupérin A,Le Péchoux C,Rolland E,et al.Meta-analysis of concomitant versus sequential radiochemotherapy in locally advanced non-small-cell lung cancer[J].Clin Oncol,2010,28(13):2181-2190.
4 孙新东,岳金波,赵汉玺,等.从局部复发状况探讨非小细胞肺癌适形放疗的靶区勾画[J].中华肿瘤杂志,2009,31(6):454-455.
5 Trakul N,Harris JP,Le QT,et al.Stereotactic ablative radiotherapy for reirradiation of locally recurrent lung tumors[R].Journal of Thoracic Oncology,2012,7(9):1462-1465.
6 McAvoy SA,Ciura KT,Rineer JM,et al.Feasibility of proton beam therapy for reirradiation of locoregionally recurrent non-small cell lung cancer[J].Radiotherapy and Oncology,2013,109(1):38-44.
7 董昭,李琦,秦庆亮,等.立体定向放射治疗联合化疗治疗放疗后局部复发非小细胞肺癌的疗效[J].肿瘤,2009,29(12):1133-1136.
8 Kelly P,Balter PA,Rebueno N,et al.Stereotactic body radiation therapy for patients with lung cancer previously treated with thoracic radiationr[J].Int Radiat Oncol Biol Phys,2010,78(5):1387-1393.
9 Jeremi＇c B,Videtic GM.Chest reirradiation with external beam radiotherapy for locally recurrent non-small-cell lung cancer:a review[J].Elsevier,2011,80(4):969-977.
10 Kruser TJ,McCabe BP,Mehta MP,et al.Reirradiation for locoregionally recurrent lung cancer:outcomes in small cell and non-small cell lung arcinoma[J].Am J Clin Oncol,2014,37(1):70-76.
11 Trovo M,Minatel E,Durofil E,et al.Stereotactic body radiation therapy for re-irradiation of persistent or recurrent non-small cell lung cancer[J].Radiation Oncology,2014,88(5):1114-1119.
12 Grills IS,Yan D,Martinez AA,et al.Potential for reduced toxicity and dose escalation in the treatment of inoperable non-small-cell lung cancer:a comparison of intensity-modulated radiation therapy(IMRT),3D conformal radiation,and elective nodal irradiation[J].Int J Radiat Oncol Biol Phys,2003,57(3):875-890.
13 Stewart FA.Re-treatment after ful-course radiotherapy:is it a viable option?[J].Acta Oncologica,1999,38(7):855-862.
14 Okamoto Y,Murakami M,Yoden E,et al.Reirradiation for locally recurrent lung cancer previously treated with radiation therapy[J].Int J Radiation Oncology Biol Phys,2002,52(2):390-396.
15 Peulen H,Karlsson K,Lindberg K,et al.Toxicity after reirradiation of pulmonary tumous with stereotactic body radiotherapy[J].Radiotherapy Oncology,2011,101(2):260-266.
16 殷蔚伯,谷铣之.肿瘤放射治疗学[M].第3版.北京:中国协和医科大学出版社,2002:667-681.
17 Tada T,Fukuda H,Matsui K,et al.Non-small-cell lung cancer:reirradiation for loco-regional relapse previously treated with radiation therapy[J].Clin Oncol,2005,10(4):247-250.
18 Griffioen GH,Dahele M,de Haan PF,et al.High-dose,conventionally fractionated thoracic reirradiation for lung tumors[J].Lung Cancer,2014,83(3):356-362.
19 Cetingoz R,Arikan-Alicikus Z,Nur-Demiral A,et al.Is re-irradiation effective in symptomatic local recurrence of non small cell lung cancer patients? A single institution experience and review of the literature[J].J Buon,2009,14(1):33-40.
20 Gressen EL,Werne-Wasik M,Cohn J,et al.Thoracic reirradiation for symptomatic relief after prior radiotherapeutic managementfor lung cancer[J].Am J Clin Oncol,2000,23(2):160-163.
21 Yoshitake T,Shioyama Y,Nakamura K,et al.Definitive fractionated reirradiation for local recurrence following stereotactic body radiotherapy for primary lung cancer[J].Anticancer Research,2013,33(12):5649-5653.

[1]	SHI Xiaokang, DING Youming, WANG Bin, YU Bin, XU Yu. Expression and clinical significance of UBE2T in primary liver cancer [J]. PRACTICAL ONCOLOGY JOURNAL, 2019, 33(2): 128-133.
[2]	MA Jianli, ZHANG Minghui, JI Hongfei, XU Xiangying. Clinical significance of combined detection of PD-L1 protein and CD8⁺TILs in resected lung adenocarcinoma [J]. PRACTICAL ONCOLOGY JOURNAL, 2019, 33(1): 40-46.
[3]	ZHANG Pan, ZHANG Di, DAI Xiaobo. Advanced in re-radiotherapy for recurrent nasopharyngeal carcinoma [J]. PRACTICAL ONCOLOGY JOURNAL, 2019, 33(1): 92-96.
[4]	XU Bing, HUANG Suqin, WU Linlan, WEI Jianwei, YANG Xiaomei, ZHAO Zhiping, CHEN Yi, JIANG Xiaozhi. Therapeutic effect of sequential local injection of heterogeneic lymphocytes and autologus lymphocytes on transplanted hepatocarcinoma in mice [J]. PRACTICAL ONCOLOGY JOURNAL, 2018, 32(6): 493-497.
[5]	BIAN Xiusen, LI Guang, GUAN Xinyu, ZHANG Yi, DI Chang, MA Can. Molecular mechanism of UHRF1 inhibiting proliferation of lung adenocarcinoma cells by regulating autophagy [J]. PRACTICAL ONCOLOGY JOURNAL, 2018, 32(6): 498-502.
[6]	WANG Lei, JIANG Huanyu, SONG Kaibin. miR-219 regulates PRKCI expression in tongue squamous cell carcinoma [J]. PRACTICAL ONCOLOGY JOURNAL, 2018, 32(6): 510-514.
[7]	WANG Yalong, LYU Zhangyan, ZHANG Fan, FENG Xiaoshuang, WEI Luopei, LI Xin, WEN Yan, GAO Yushun, XUE Qi, GAO Shugeng, TAN Fengwei. Relationship between human papillomavirus infection and prognosis of lung cancer:A meta-analysis [J]. PRACTICAL ONCOLOGY JOURNAL, 2018, 32(6): 520-526.
[8]	LI Wanzhen, YIN Jun, LI Ping, LIN Xiaohui, ZHANG Guoqian, ZHANG Shuxu. The expression and role of miR-17 in radioresistant cells of non-small cell lung cancer [J]. PRACTICAL ONCOLOGY JOURNAL, 2018, 32(5): 391-397.
[9]	CHEN Lin, WANG Enxiang, LIU Qunyou, ZHONG Ying, ZHOU Guoliang, ZHAO Xiyan. CDX2 gene inhibits of colon cancer cell proliferation by NF-κB signaling pathway [J]. PRACTICAL ONCOLOGY JOURNAL, 2018, 32(5): 398-403.
[10]	WANG Yiran, HUANG Wei, YIN Lei, LIU Lin, ZHOU Xiaoping, NIU Xingjian, YANG Yue, AN Weiwei, JI Hongfei. The ratio of neutrophil to lymphocyte in the efficacy and prognosis of concurrent chemoradiotherapy in patients with cervical cancer and its clinical significance [J]. PRACTICAL ONCOLOGY JOURNAL, 2018, 32(5): 404-409.
[11]	CAI Jing, HOU Yue. The expression and clinical significance of serum miR-195 in patients with non-small cell lung cancer [J]. PRACTICAL ONCOLOGY JOURNAL, 2018, 32(5): 415-419.
[12]	HE Wei, MU Qiming, WANG Gang, WAN Bo, LIAO Bo, YANG Juan. Expression of TACC3 and p53 protein in primary liver cancer and its clinical significance [J]. PRACTICAL ONCOLOGY JOURNAL, 2018, 32(5): 420-425.
[13]	CHEN Zhaohong,HE Yingying,ZHANG Youcai,LU Dingyu. Effects of SOX7 overexpression on proliferation and other biological characteristics of gallbladder carcinoma GBC-SD cells and its mechanism [J]. PRACTICAL ONCOLOGY JOURNAL, 2018, 32(4): 293-297.
[14]	HAO He,LI Xing,WU Lingyan,GUO Xiaojin,CAO Jing,YANG Chunwang,ZHANG Xiao,WANG Zhiyu. Expression of PD-1,CTLA-4 and BLTA in the peripheral blood of patients with esophageal squamous cell carcinoma and its clinical implications [J]. PRACTICAL ONCOLOGY JOURNAL, 2018, 32(4): 303-308.
[15]	CUI Xiaoyan,TU Qing,GAN Jianhui. Comparison between nalbuphine and oxycodone applied for patient controlled analgesia on postoperative immunological factor levels in patients with non-small cell lung cancer [J]. PRACTICAL ONCOLOGY JOURNAL, 2018, 32(4): 309-314.

Progresses on reirradiation for locally recurrence of non-small-cell lung cancer patients after radiotherapy and chemotherapy

PDF (PC)

Knowledge

Abstract

Cite this article

share this article

References

Related Articles 15

Recommended Articles

Metrics

Comments